Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

APDN

Applied Dna Sciences Inc

Jul 26 • 04:00PM ET

0.4101

Dollar change -0.0149
Percentage change -3.51	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-17.21	Insider Own	1.16%	Shs Outstand	9.01M	Perf Week	1.69%
Market Cap	3.70M	Forward P/E	-	EPS next Y	-0.95	Insider Trans	0.00%	Shs Float	8.91M	Perf Month	0.64%
Income	-12.50M	PEG	-	EPS next Q	-0.49	Inst Own	10.72%	Short Float	6.60%	Perf Quarter	-91.80%
Sales	5.52M	P/S	0.67	EPS this Y	49.41%	Inst Trans	155.85%	Short Ratio	0.52	Perf Half Y	-96.75%
Book/sh	-0.07	P/B	-	EPS next Y	87.65%	ROA	-86.54%	Short Interest	0.59M	Perf Year	-98.64%
Cash/sh	0.35	P/C	1.17	EPS next 5Y	-	ROE	-246.31%	52W Range	0.33 - 37.20	Perf YTD	-96.68%
Dividend Est.	-	P/FCF	-	EPS past 5Y	45.52%	ROI	-2946.59%	52W High	-98.90%	Beta	0.07
Dividend TTM	-	Quick Ratio	1.54	Sales past 5Y	83.23%	Gross Margin	12.88%	52W Low	24.27%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	1.66	EPS Y/Y TTM	-100.73%	Oper. Margin	-261.64%	RSI (14)	29.93	Volatility	7.79% 14.81%
Employees	55	Debt/Eq	-	Sales Y/Y TTM	-68.52%	Profit Margin	-226.55%	Recom	2.00	Target Price	1.50
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	-682.38%	Payout	-	Rel Volume	0.24	Prev Close	0.43
Sales Surprise	-2.25%	EPS Surprise	-18.00%	Sales Q/Q	-78.91%	Earnings	May 10 AMC	Avg Volume	1.14M	Price	0.41
SMA20	-4.83%	SMA50	-49.76%	SMA200	-95.68%	Trades		Volume	272,446	Change	-3.51%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-12-21	Initiated	ROTH Capital	Buy	$24
Jan-14-21	Reiterated	H.C. Wainwright	Buy	$18 → $14
Dec-18-20	Reiterated	H.C. Wainwright	Buy	$20 → $12
Jul-20-20	Reiterated	H.C. Wainwright	Buy	$18 → $22
Jul-02-20	Initiated	H.C. Wainwright	Buy	$18
Nov-14-16	Reiterated	Maxim Group	Buy	$8 → $6
May-13-16	Reiterated	Maxim Group	Buy	$13 → $9
Oct-08-15	Reiterated	Maxim Group	Buy	$9 → $13
May-26-15	Initiated	The Benchmark Company	Speculative Buy	$5
Feb-10-15	Reiterated	Maxim Group	Buy	$7 → $9
Jan-13-15	Initiated	Maxim Group	Buy	$7

Show Previous Ratings

Jul-25-24 09:00AM	Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability (ACCESSWIRE)
Jul-18-24 10:00AM	U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract (ACCESSWIRE)
Jul-10-24 07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Jul-02-24 07:40AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace) -19.25%
Jun-27-24 12:00PM	Applied DNA Sciences (APDN) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:15AM	Loading…
Jun-20-24 09:15AM	Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics (ACCESSWIRE) +5.45%
Jun-18-24 09:00AM	Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing (ACCESSWIRE)
Jun-13-24 09:00AM	Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health (ACCESSWIRE) +6.45%
Jun-05-24 09:00AM	Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform (ACCESSWIRE) +16.48%
May-28-24 09:30AM	Applied DNA Announces Pricing of $12 Million Public Offering (ACCESSWIRE) -69.85%
May-13-24 08:55AM	Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML (ACCESSWIRE) -10.72%
May-10-24 08:53PM	APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace) -7.75%
05:15PM	Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results (ACCESSWIRE)
09:00AM	Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement (ACCESSWIRE)
05:21AM	Loading…
May-09-24 05:21AM	Xinjiang cotton widespread despite US UFLPA legislation (Just Style)
May-07-24 12:22PM	Banned Chinese cotton found in 19% of US and global retailers' merchandise, study shows (Reuters)
12:17PM	CORRECTED-Banned Chinese cotton found in 19% of US and global retailers' merchandise, study shows (Reuters)
Apr-25-24 09:00AM	Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program (ACCESSWIRE)
Apr-22-24 04:05PM	Applied DNA Announces 1-For-20 Reverse Stock Split (ACCESSWIRE) -12.12%
Mar-18-24 09:00AM	Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start (ACCESSWIRE) +19.57%
Mar-14-24 10:00AM	Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress (ACCESSWIRE) -23.08%
Feb-21-24 09:40AM	Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year? (Zacks)
Feb-10-24 08:48AM	Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-09-24 06:17AM	Q1 2024 Applied DNA Sciences Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-08-24 05:40PM	Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:40PM	Applied DNA Sciences: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results (ACCESSWIRE)
Feb-05-24 01:00PM	Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024 (ACCESSWIRE)
Feb-02-24 04:15PM	Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE)
08:00AM	Loading…
Jan-31-24 08:00AM	Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (ACCESSWIRE)
Dec-14-23 08:00AM	Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnologys mRNA Manufacturing Workflow (ACCESSWIRE) -7.89%
Dec-12-23 08:10AM	Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript (Insider Monkey) -19.96%
Dec-07-23 09:55PM	APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -18.43%
04:55PM	Applied DNA Sciences: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results (ACCESSWIRE)
Dec-05-23 08:30AM	Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023 (ACCESSWIRE)
Nov-28-23 08:30AM	Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application (ACCESSWIRE)
Nov-16-23 08:30AM	Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA) (ACCESSWIRE) +5.25%
Nov-09-23 09:15AM	Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform (ACCESSWIRE)
Sep-14-23 09:00AM	Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals (ACCESSWIRE)
Sep-06-23 09:00AM	Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs (ACCESSWIRE)
Aug-29-23 09:00AM	Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit (ACCESSWIRE)
Aug-23-23 09:30AM	Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production (ACCESSWIRE) +7.41%
Aug-10-23 04:56PM	Applied DNA Sciences: Fiscal Q3 Earnings Snapshot (Associated Press Finance) +10.06% -10.86%
04:05PM	Applied DNA Reports Third Quarter Fiscal 2023 Financial Results and Provides Corporate Update (ACCESSWIRE)
Aug-08-23 08:15AM	ADT (ADT) Q2 Earnings and Revenues Miss Estimates (Zacks)
Aug-07-23 11:00AM	Applied DNA to Report Third Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, August 10, 2023 (ACCESSWIRE)
Jul-27-23 06:24PM	3 Penny Stocks to Buy Before the Breakout (InvestorPlace) +6.62%
Jul-18-23 10:00AM	Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences (ACCESSWIRE)
Jul-13-23 07:15AM	Applied DNA Acquires RNA Polymerase Developer Spindle Biotech, Launches LineaIVT(TM) Platform to Substantially Improve mRNA Manufacturing and Broaden Market Reach (ACCESSWIRE) +11.81%
Jun-08-23 11:00AM	Applied DNA Announces Presentation at Upcoming Healthcare Investor Conference (ACCESSWIRE) -6.83%
May-16-23 11:53AM	Applied DNA Sciences, Inc. (NASDAQ:APDN) Q2 2023 Earnings Call Transcript (Insider Monkey)
May-11-23 04:56PM	Applied DNA Sciences: Fiscal Q2 Earnings Snapshot (AP Finance)
04:05PM	Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update (ACCESSWIRE)
May-03-23 03:00PM	Applied DNA to Report Second Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, May 11, 2023 (Business Wire)
Apr-07-23 12:00PM	Applied DNA's CertainT® Supply Chain Traceability Platform Featured in New York Times Article About the Need for Transparency and Compliance in Global Supply Chains Under Recently Passed U.S. Federal Regulation (Business Wire)
Mar-29-23 09:00AM	Applied DNA Achieves Milestone for Large-Scale linearDNA Production, Delivers Largest Single Shipment by Volume to Date (Business Wire)
Mar-22-23 09:35AM	Applied DNA Submits Validation Package to New York State Department of Health for Approval of Pharmacogenomic (PGx) Assay (Business Wire) +10.58%
Feb-15-23 12:00PM	What Makes Applied DNA Sciences (APDN) a New Buy Stock (Zacks) +5.10%
Feb-12-23 10:43AM	Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2023 Earnings Call Transcript (Insider Monkey)
Feb-10-23 09:34AM	Applied DNA Announces New York State Award Valued at Up To $1.5 Million to Support Establishment of cGMP linearDNA Production Capacity on Long Island, New York (Business Wire)
Feb-09-23 04:05PM	Applied DNA Reports First Quarter Fiscal 2023 Financial Results (Business Wire) -6.78%
Feb-02-23 10:00AM	Applied DNA to Report First Quarter Fiscal 2023 Financial Results and Host Investor Conference Call and Webcast on Thursday, February 9, 2023 (Business Wire)
Jan-05-23 09:45AM	Applied DNA Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of linearDNA as a New Class of DNA-Based Vaccines (Business Wire)
Dec-22-22 10:52AM	Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Dec-16-22 05:32AM	Applied DNA Sciences Full Year 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Dec-14-22 04:10PM	Applied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial Results (Business Wire)
Dec-12-22 10:00AM	Applied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022 (Business Wire) +6.47%
Nov-10-22 09:25AM	RBC Bearings (RBC) Q2 Earnings and Revenues Top Estimates (Zacks) +6.79%
Nov-09-22 06:25PM	Alta Equipment (ALTG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Nov-08-22 07:05PM	Alarm.com Holdings (ALRM) Q3 Earnings and Revenues Beat Estimates (Zacks)
Oct-24-22 09:30AM	Applied DNA to Establish North Americas First Enzymatic (Cell Free) Large-Scale cGMP DNA Manufacturing Capacity in Suffolk County, New York (Business Wire) -8.81%
Oct-10-22 11:19AM	Applied DNA Sciences Stock Surges On largest LinearDNA Contract (Benzinga) +70.97%
09:45AM	Applied DNA Announces Receipt of Largest Single Purchase Order for LinearDNA To-Date (Business Wire)
Sep-30-22 09:00AM	Applied DNAs Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets (Business Wire) -7.38%
Sep-08-22 10:00AM	Applied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate Application of LinearDNA Platform for Veterinary Health Applications (Business Wire)
Sep-07-22 12:00PM	Applied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (Business Wire) -5.05%
Sep-06-22 08:00AM	Applied DNA Launches Monkeypox Testing Service (Business Wire) +7.22%
Aug-31-22 06:25PM	The 5 Bestand 5 WorstNasdaq Stocks in August (Barrons.com) +17.74% -10.90%
Aug-19-22 09:45AM	Applied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of Health (Business Wire) +14.17%
Aug-17-22 09:29AM	7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher (InvestorPlace) +11.41%
06:15AM	Analyst Forecasts For Applied DNA Sciences, Inc. (NASDAQ:APDN) Are Surging Higher (Simply Wall St.)
Aug-11-22 06:55PM	Applied DNA Sciences (APDN) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -18.14%
04:10PM	Applied DNA Reports Third Quarter Fiscal 2022 Financial Results (Business Wire)
Aug-10-22 05:15PM	Energous (WATT) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -7.24%
09:30AM	Applied DNA Biotherapeutics Subsidiary Reports LinearDNA Platform Development Milestone: First Successful Administration of LinearDNA In Vivo via Lipid Nanoparticles (LNP) (Business Wire)
09:13AM	10 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat (Insider Monkey)
Aug-09-22 11:30AM	Applied DNA Awarded Extension of Health Services Contract with The City University of New York (Business Wire)
08:15AM	Applied DNA Receives Approximately $3.6 Million in Net Proceeds from Warrant Exercise (Business Wire)
Aug-08-22 04:05PM	Applied DNA to Host Conference Call and Webcast Discussing Fiscal 2022 Third Quarter Results and Corporate Updates (Business Wire) -16.47%
01:15PM	Applied DNA Announces Closing of Upsized $12 Million Public Offering (Business Wire)
Aug-05-22 11:37AM	Applied DNA stock surges again, for 4-day gain of more than 870% (MarketWatch)
Aug-04-22 10:43AM	Applied DNA Sciences pulls back after 6-fold surge in 2 days, after 'upsized' equity offering prices (MarketWatch) +40.00%
09:16AM	Applied DNA Announces Pricing of $12 Million Upsized Public Offering, Priced at a Premium to Market Under Nasdaq Rules (Business Wire)
08:15AM	ADT (ADT) Tops Q2 Earnings and Revenue Estimates (Zacks)
Aug-03-22 09:38AM	Will Applied DNA Sciences (NASDAQ:APDN) Spend Its Cash Wisely? (Simply Wall St.) +46.43%
08:41AM	Applied DNA stock soars more than 80% active trading, after quadrupling in the previous session (MarketWatch)
Aug-02-22 02:14PM	Applied DNA Sciences blasts more than 350% higher after initiating validation of monkeypox virus test (MarketWatch) +311.16%
01:02PM	Applied DNA Sciences Shares Triples After Monkeypox Diagnostic Test Update (Benzinga)

Applied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment offers DNA detection via PCR to provide and develop clinical molecular diagnostics and genetic testing services. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

APDN

Applied Dna Sciences Inc

Upgrade your FINVIZ experience